经颈静脉门体静脉分流术精准技术与合理分流道的建立*

doi:10.3969/j.issn.1672-5069.2022.01.002

Abstract

Zhang Yu, Liu Fuquan. Precision technique and rational shunt in transjugular intrahepatic portosystemic shunt[J]. Journal of Practical Hepatology, 2022, 25(1): 5-8.

[1] Sanyal A J, Bosch J, Blei A, et al. Portal hypertension and its complications. Gastroenterology, 2008, 134(6): 1715-1728.
[2] Simonetto D A, Liu M, Kamath P S. Portal hand related complications: Diagnosis and management. Mayo Clin Proc, 2019, 94(4): 714-726.
[3] Turcol L, Garcia-Tsao G. Portal hypertension: Pathogenesis and diagnosis. Clin Liver Dis, 2019, 23(4): 573-587.
[4] 中华医学会消化病学分会消化介入学组. 经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见. 中华消化杂志, 2014, 30(3): 210-213.
[5] Strunk K H, Marinova M. Transjugular intrahepatic portosystemic shunt (TIPS): Pathophysiologic basics, actual indications and results with review of the literature. Rofo, 2018, 190(8): 701-711.
[6] Tripathi D, Stanley A J, Hayes P C, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut, 2020, 69(7): 1173-1192.
[7] Fidelman N, Kwan S W, Lalerge J M, et al. The transjugular intrahepatic portosystemic shunt: an update. AJR, 2012, 199(4): 746-755.
[8] Meine T C, Dewald C L A, Becker L S, et al. Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy. Abdom Radiol (NY), 2020, 45(11): 3934-3943.
[9] Keller F S, Farsad K, Rösch J. The transjugular intrahepatic portosystemic shunt: Technique and instruments. Tech Vasc Interv Radiol, 2016, 19(1): 2-9.
[10] Shah R P, Sze D Y. Complications during transjugular intrahepatic portosystemic shunt creation. Tech Vasc Interv Radiol, 2016, 19(1): 61-73.
[11] 经颈静脉肝内门体静脉分流术临床技术指南. 中华放射学杂志, 2004, 38(12): 1329-1332.
[12] Modaresi Esfeh J, Aasari-Gilani K. Transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol, 2020, 32(6): 762-763.
[13] Cheng Z, Wang F, Liu J. Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access. Clin Mol Hepatol, 2019, 25(4): 417-419.
[14] Zhao M, Yue Z, Zhao H, et al. Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis. Sci Rep, 2016, 6: 33069.
[15] 张裕, 刘福全. 门静脉系统血栓的抗凝药物选择. 临床肝胆病杂志, 2018, 34(10): 15-20.
[16] Parker R. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Clin Liver Dis, 2014, 18(2): 319-334.
[17] Huang Z, Yao Q, Zhu J, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging, 2021, 102(5): 279-285.
[18] He F L, Wang L, Yue Z D, et al. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol, 2014, 20(33): 11835-11839.

Precision technique and rational shunt in transjugular intrahepatic portosystemic shunt

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zeng Yi, Li Guo, Li Hongcui, et al. Efficacy of ursodeoxycholic acid in the treatment of patients with primary biliary cholangitis and cirrhosis and its effect on serum Nrf2 and HO-1 levels [J]. Journal of Practical Hepatology, 2022, 25(2): 211-214.
[2]	Hao Yuting, Lin Jie, Qin Jie. Clinical implication of serum aquaporin-8 and aquaporin-9 in patients with hepatitis B-induced liver cirrhosis receiving long-term entecavir therapy [J]. Journal of Practical Hepatology, 2022, 25(2): 243-246.
[3]	Wang Benxian, Li Wei, Li Dongsheng, et al. Cell-free and concentrated ascites reinfusion therapy for patients with decompensated cirrhosis [J]. Journal of Practical Hepatology, 2022, 25(2): 247-250.
[4]	Chen Jing, Zhu Yueyong. Non-invasive diagnosis of portal hypertension in patients with liver cirrhosis: serum markers or imaging? [J]. Journal of Practical Hepatology, 2022, 25(1): 9-12.
[5]	Li Yanle, Liu Xiaoyu, Yao Jianning, et al. Serum ammonia level changes and its correlation to cognitive impairment in patients with hepatitis B cirrhosis and hepatic encephalopathy [J]. Journal of Practical Hepatology, 2022, 25(1): 74-78.
[6]	Wang Jing, Bi Ning, Fang Liang, et al. Correlation of blood CD64 index to intestinal mucosal barrier functions in patients with hepatitis B cirrhosis and spontaneous bacterial peritonitis [J]. Journal of Practical Hepatology, 2022, 25(1): 79-82.
[7]	Wu Ling, Li Feng. Administration of non-selective beta-blockers in treatment of patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2022, 25(1): 144-147.
[8]	Shi Cuicui, Liu Yanjun, Zhang Ruinan, et al. Dyslipidemia in patients with liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 859-862.
[9]	Liu Mei, Shi Yonghong, Ying Juan, et al. Prevalence of nosocomial infection and resistance of pathogens in patients with decompensated liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 863-866.
[10]	Liu Yuling, Zhen Zengguo, Wang Huijuan, et al. Effects of probiotics on intestinal barrier function of patients with liver cirrhosis complicated by spontaneous bacterial peritonitis [J]. Journal of Practical Hepatology, 2021, 24(6): 867-870.
[11]	Xing Li, Du Qianying, Jiang Yanli, et al. Impact of segmented injection of contrast agent on hepatic vein imaging by CT angiography in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 871-874.
[12]	Huang Liou, Wu Chunrong, Xu Dan, et al. Efficacy of continuous renal replacement therapy without heparinization in patients with liver cirrhosis complicated by hepatic encephalopathy [J]. Journal of Practical Hepatology, 2021, 24(6): 875-878.
[13]	Ye Dong, Zhang Junxia, LiJie, et al. Risk factors of rebleeding in hepatitis B liver cirrhotics with esophageal varices bleeding after endoscopic variceal ligation [J]. Journal of Practical Hepatology, 2021, 24(6): 879-882.
[14]	Han Chengmei, Han Yongfeng, Wang Chunhua. Risk factors for acute kidney injury in patients with hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 883-886.
[15]	Wang Jing, Bi Ning, Fang Liang, et al. Efficacy of transarterial intrahepatic transplantation of autologous bone marrow stem cells in the treatment of patients with decompensated hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 887-890.